AMICUS THERAPEUTICS, INC.

FOLD · Nasdaq · SIC 2834: Pharmaceutical Preparations
221
SEC Filings

Business Summary

PART I Overview We are a leading, global biotechnology company with a clear and compelling mission to develop and deliver transformative medicines for people living withrarediseases. With extraordinary patient focus, we strive toredefineexpectationsinraredisease. Our two marketed therapies are Galafold , the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda , a novel two-component treatment for adults living with late-onset Po...

Next Earnings

Q2 FY2026 — expected 2026-07-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionFOLDdiscussed_in_filing Cybersecurity
topic_mentionFOLDdiscussed_in_filing Trusted Computing
topic_mentionFOLDdiscussed_in_filing Blockchain & Crypto
topic_mentionFOLDdiscussed_in_filing Supply Chain
topic_mentionFOLDdiscussed_in_filing Regulation
topic_mentionFOLDdiscussed_in_filing Enterprise
topic_mentionFOLDdiscussed_in_filing Healthcare & Bio
topic_mentionFOLDdiscussed_in_filing Platform & Ecosystem
topic_mentionFOLDdiscussed_in_filing Sovereign & Government
topic_mentionFOLDdiscussed_in_filing Cybersecurity
topic_mentionFOLDdiscussed_in_filing Trusted Computing
topic_mentionFOLDdiscussed_in_filing Blockchain & Crypto
topic_mentionFOLDdiscussed_in_filing Supply Chain
topic_mentionFOLDdiscussed_in_filing Regulation
topic_mentionFOLDdiscussed_in_filing Enterprise
topic_mentionFOLDdiscussed_in_filing Healthcare & Bio
topic_mentionFOLDdiscussed_in_filing Platform & Ecosystem
topic_mentionFOLDdiscussed_in_filing Sovereign & Government
topic_mentionFOLDdiscussed_in_filing Cybersecurity
topic_mentionFOLDdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-202025-12-310001178879-26-000005EDGAR102K words
2025-02-192024-12-310001178879-25-000003EDGAR
2024-02-282023-12-310001178879-24-000003EDGAR
2023-03-012022-12-310001178879-23-000004EDGAR
2022-02-242021-12-310001178879-22-000006EDGAR
2021-03-012020-12-310001178879-21-000004EDGAR
2020-03-022019-12-310001178879-20-000015EDGAR
2019-02-282018-12-310001178879-19-000024EDGAR
2018-03-012017-12-310001047469-18-001199EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001178879-25-000015EDGAR16K words
2025-07-312025-06-300001178879-25-000011EDGAR
2025-05-012025-03-310001178879-25-000006EDGAR
2024-11-062024-09-300001178879-24-000013EDGAR
2024-08-082024-06-300001178879-24-000009EDGAR
2024-05-092024-03-310001178879-24-000006EDGAR
2023-11-082023-09-300001178879-23-000016EDGAR
2023-08-082023-06-300001178879-23-000013EDGAR
2023-05-102023-03-310001178879-23-000009EDGAR
2022-11-072022-09-300001178879-22-000018EDGAR
2022-08-042022-06-300001178879-22-000014EDGAR
2022-05-102022-03-310001178879-22-000011EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-030001140361-26-007544EDGAR2K words
2026-02-200001104659-26-018127EDGAR
2026-01-260001140361-26-002299EDGAR
2025-12-190001140361-25-046134EDGAR
2025-11-040001104659-25-105927EDGAR
2025-07-310001104659-25-072447EDGAR
2025-06-050001104659-25-056821EDGAR
2025-05-010001104659-25-043008EDGAR
2025-05-010001104659-25-042841EDGAR
2025-02-210001104659-25-016127EDGAR

221 total filings indexed. 190 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001178879
TickerFOLD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f64b5265cb076293d1666b00c65cdb8ab76cb4cfb450ce5a409bceb4d5d27bdd
parent: 12daf075d8693fdd08cee5f03aaaf962cd1259cfb3e625c5d775581b7a57ec99
content hash: 0dd7b6a316c9fb456ef2488d61ef8e81a0afe6d1e006cee8e964a0be8beb45b4
signed: 2026-04-13T04:45:06.569Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf